The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults

European Journal of Nutrition

Volumn 55, Issue 2, 2016, Pages 651-663

  Edel, Andrea L ^a   Patenaude, Amanda F ^a   Richard, Melanie N ^a   Dibrov, Elena ^a   Austria, J Alejandro ^a   Aukema, Harold M ^a   Pierce, Grant N ^a   Aliani, Michel ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alpha linolenic acid; Cardiovascular disease; Enterolignans; Flaxseed; Platelets

Indexed keywords

11 OXOTHROMBOXANE B2; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ENTEROLIGNAN DERIVATIVE; ICOSAPENTAENOIC ACID; LIGNAN DERIVATIVE; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID; SECOISOLARICIRESINOL; SECOISOLARICIRESINOL DIGLUCOSIDE; THROMBOXANE; THROMBOXANE B2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; 11-DEHYDRO-THROMBOXANE B2; BUTANEDIOL; CHOLESTEROL; GLUCOSIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT MEDICINAL PRODUCT; UNSATURATED FATTY ACID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LINSEED; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINE LEVEL; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; DIET; DRUG EFFECTS; FLAX; MIDDLE AGED; PLANT SEED; RANDOMIZED CONTROLLED TRIAL; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA-LINOLENIC ACID; BUTYLENE GLYCOLS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FLAX; GLUCOSIDES; HUMANS; MALE; MIDDLE AGED; PLANT PREPARATIONS; PLATELET AGGREGATION; SEEDS; THROMBOXANE B2; TRIGLYCERIDES; YOUNG ADULT;

EID: 84959138055     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0885-2     Document Type: Article

References (70)

1. Prasad K (2009) Flaxseed and cardiovascular health. J Cardiovasc Pharmacol 54:369–377. doi:10.1097/FJC.0b013e3181af04e5
2. Bloedon LT, Szapary PO (2004) Flaxseed and cardiovascular risk. Nutr Rev 62:18–27
3. Dupasquier CM, Weber AM, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, Kroeger EA, Gilchrist JS et al (2006) Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 291:H2987–H2996. doi:10.1152/ajpheart.01179.2005
4. Dupasquier CM, Dibrov E, Kneesh AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, Moghadasian MH, Pierce GN (2007) Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 293:H2394–H2402. doi:10.1152/ajpheart.01104.2006
5. Francis AA, Deniset JF, Austria JA, LaVallee RK, Maddaford GG, Hedley TE, Dibrov E, Pierce GN (2013) The effects of dietary flaxseed on atherosclerotic plaque regression. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.00606.2012
6. Ander BP, Weber AR, Rampersad PP, Gilchrist JS, Pierce GN, Lukas A (2004) Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic Rabbits. J Nutr 134:3250–3256
7. Lucas EA, Lightfoot SA, Hammond LJ, Devareddy L, Khalil DA, Daggy BP, Smith BJ, Westcott N, Mocanu V et al (2004) Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 173:223–229. doi:10.1016/j.atherosclerosis.2003.12.032
8. Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, Maddaford TG, Ramjiawan B, Aliani M et al (2013) Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 62:1081–1089. doi:10.1161/hypertensionaha.113.02094
9. Caligiuri SP, Edel AL, Aliani M, Pierce GN (2014) Flaxseed for hypertension: implications for blood pressure regulation. Curr Hypertens Rep 16:499. doi:10.1007/s11906-014-0499-8
10. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X (2009) Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 90:288–297. doi:10.3945/ajcn.2009.27469
11. Edel AL, Rodriguez-Leyva D, Maddaford TG, Caligiuri SPB, Alejandro Austria J, Weighell W, Guzman R, Aliani M, Pierce GN (2015) Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease. J Nutr. doi:10.3945/jn.114.204594
12. Paschos GK, Magkos F, Panagiotakos DB, Votteas V, Zampelas A (2007) Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 61:1201–1206. doi:10.1038/sj.ejcn.1602631
13. Takeuchi H, Sakurai C, Noda R, Sekine S, Murano Y, Wanaka K, Kasai M, Watanabe S, Aoyama T, Kondo K (2007) Antihypertensive effect and safety of dietary alpha-linolenic acid in subjects with high-normal blood pressure and mild hypertension. J Oleo Sci 56:347–360
14. Djoussé L, Arnett DK, Pankow JS, Hopkins PN, Province MA, Ellison RC (2005) Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI family heart study. Hypertension 45:368–373. doi:10.1161/01.HYP.0000154679.41568.e6
15. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N (2006) Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54:184–201. doi:10.1207/s15327914nc5402_5
16. Penalvo JL, Haajanen KM, Botting N, Adlercreutz H (2005) Quantification of lignans in food using isotope dilution gas chromatography/mass spectrometry. J Agric Food Chem 53:9342–9347. doi:10.1021/jf051488w
17. Smeds AI, Eklund PC, Sjöholm RE, Willför SM, Nishibe S, Deyama T, Holmbom BR (2007) Quantification of a broad spectrum of lignans in cereals, oilseeds, and nuts. J Agric Food Chem 55:1337–1346. doi:10.1021/jf0629134
18. Mazur W, Duke J, Wähälä K, Rasku S, Adlercreutz H (1998) Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. J Nutr Biochem 9:193–200. doi:10.1016/S0955-2863(97)00184-8
19. Axelson M, Setchell KDR (1981) The excretion of lignans in rats—evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123:337–342
20. Adlercreutz H, Hockerstedt K, Bannwart C, Bloigu S, Hamalainen E, Fotsis T, Ollus A (1987) Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 27:1135–1144
21. Setchell KDR, Brown NM, Zimmer-Nechemias L, Wolfe B, Jha P, Heubi JE (2014) Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food Funct 5:491–501. doi:10.1039/C3FO60402K
22. Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU (1999) Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202:91–100
23. Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts LJ, Morrow JD, Adlercreutz H, Salonen JT (2002) Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 160:465–469
24. Pan A, Sun J, Chen Y, Ye X, Li H, Yu Z, Wang Y, Gu W, Zhang X et al (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2:e1148. doi:10.1371/journal.pone.0001148
25. Zhang W, Wang X, Liu Y, Tian H, Flickinger B, Empie MW, Sun SZ (2008) Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99:1301–1309. doi:10.1017/S0007114507871649
26. Cornish SM, Chilibeck PD, Paus-Jennsen L, Biem HJ, Khozani T, Senanayake V, Vatanparast H, Little JP, Whiting SJ, Pahwa P (2009) A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 34:89–98. doi:10.1139/h08-142
27. Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, Szapary PO (2008) Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27:65–74
28. Brown L, Rosner B, Willett WW, Sacks FM (1999) Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69:30–42
29. Austria JA, Richard MN, Chahine MN, Edel AL, Malcolmson LJ, Dupasquier CM, Pierce GN (2008) Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 27:214–221
30. Kuijsten A, Arts IC, van’t Veer P, Hollman PC (2005) The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed. J Nutr 135:2812–2816
31. Coulman KD, Liu Z, Michaelides J, Quan Hum W, Thompson LU (2009) Fatty acids and lignans in unground whole flaxseed and sesame seed are bioavailable but have minimal antioxidant and lipid-lowering effects in postmenopausal women. Mol Nutr Food Res 53:1366–1375. doi:10.1002/mnfr.200900032
32. Patenaude A, Rodriguez-Leyva D, Edel AL, Dibrov E, Dupasquier CM, Austria JA, Richard MN, Chahine MN, Malcolmson LJ, Pierce GN (2009) Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Eur J Clin Nutr 63:1123–1129. doi:10.1038/ejcn.2009.41
33. Khalatbari Soltani S, Jamaluddin R, Tabibi H, Mohd Yusof BN, Atabak S, Loh S-P, Rahmani L (2013) Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodial Int 17:275–281. doi:10.1111/j.1542-4758.2012.00754.x
34. Patade A, Devareddy L, Lucas E, Korlagunta K, Daggy B, Arjmandi B (2008) Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women. J Womens Health 17:355–366. doi:10.1089/jwh.2007.0359
35. Dodin S, Lemay A, Jacques H, Légaré F, Forest J-C, Mâsse B (2005) The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90:1390–1397. doi:10.1210/jc.2004-1148
36. Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU, Wolever TM, Jenkins DJ (1995) Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61:62–68
37. Cunnane SC, Ganguli S, Menard C, Liede AC, Hamadeh MJ, Chen ZY, Wolever TM, Jenkins DJ (1993) High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 69:443–453
38. Mandasescu S, Mocanu V, Dascalita AM, Haliga R, Nestian I, Stitt PA, Luca V (2005) Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 109:502–506
39. Mani UV, Mani I, Biswas M, Kumar SN (2011) An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus. J Diet Suppl 8:257–265. doi:10.3109/19390211.2011.593615
40. Clark WF, Parbtani A, Huff MW, Spanner E, de Salis H, Chin-Yee I, Philbrick DJ, Holub BJ (1995) Flaxseed: a potential treatment for lupus nephritis. Kidney Int 48:475–480
41. Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE (2013) Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res 33:367–375. doi:10.1016/j.nutres.2013.02.012
42. Expert Panel (2009) United States Food and Drug Administration. United States Department of Health & Human Services. Determination of the GRAS status of the addition of whole and milled flaxseed to conventional foods and meat and poultry products [cited 2015 February 2015]. http://fda.gov/ucm/groups/fdagov-public/@fdagov-foods-gen/documents/document/ucm269248.pdf
43. Nesbitt PD, Lam Y, Thompson LU (1999) Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69:549–555
44. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL (2000) Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women. Cancer Epidemiol Biomark Prev 9:1113–1118
45. Aliani M, Ryland D, Pierce GN (2011) Effect of flax addition on the flavor profile of muffins and snack bars. Food Res Int 44:2489–2496. doi:10.1016/J.Foodres.2011.01.044
46. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114–120
47. Edel AL, Aliani M, Pierce GN (2013) Supported liquid extraction in the quantitation of plasma enterolignans using isotope dilution GC/MS with application to flaxseed consumption in healthy adults. J Chromatogr B Anal Biomed Life Sci 912:24–32. doi:10.1016/j.jchromb.2012.10.030
48. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
49. Heinegard D, Tiderstrom G (1973) Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 43:305–310
50. McAdam BF, Byrne D, Morrow JD, Oates JA (2005) Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation 112:1024–1029. doi:10.1161/circulationaha.105.542696
51. Palmer ME, Haller C, McKinney PE, Klein-Schwartz W, Tschirgi A, Smolinske SC, Woolf A, Sprague BM, Ko R, Everson G et al (2003) Adverse events associated with dietary supplements: an observational study. Lancet 361:101–106. doi:10.1016/S0140-6736(03)12227-1
52. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H (2002) Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 155:472–477
53. Dodin S, Cunnane SC, Mâsse B, Lemay A, Jacques H, Asselin G, Tremblay-Mercier J, Marc I, Lamarche B et al (2008) Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 24:23–30. doi:10.1016/j.nut.2007.09.003
54. Taylor CG, Noto AD, Stringer DM, Froese S, Malcolmson L (2010) Dietary milled flaxseed and flaxseed oil improve n-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 29:72–80
55. Harper CR, Edwards MJ, DeFilipis AP, Jacobson TA (2006) Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr 136:83–87
56. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP (2006) Conversion of α-linolenic acid in humans is influenced by the absolute amounts of α-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84:44–53
57. Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris-Etherton PM (2007) Dietary α-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr 85:385–391
58. Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U (2009) Dietary α-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 139:861–868. doi:10.3945/jn.108.103861
59. Barceló-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK (2008) Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr 88:801–809
60. Akiba S, Murata T, Kitatani K, Sato T (2000) Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol Pharm Bull 23:1293–1297
61. Tsuji M, Murota SI, Morita I (2003) Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot Essent Fatty Acids 68:337–342
62. Kaur G, Cameron-Smith D, Garg M, Sinclair AJ (2011) Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res 50:28–34. doi:10.1016/j.plipres.2010.07.004
63. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T et al (2013) Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease. Am J Cardiol 111:6–11. doi:10.1016/j.amjcard.2012.08.038
64. Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H, Salonen JT (2003) Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 163:1099–1104. doi:10.1001/archinte.163.9.1099
65. Morton MS, Wilcox G, Wahlqvist ML, Griffiths K (1994) Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142:251–259
66. Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch (2014) Summary of Health Canada’s assessment of a health claim about ground whole flaxseed and blood cholesterol lowering. Ontario (Canada) Bureau of Nutritional Sciences; [cited 2015 February 17]. http://www.hc-sc.gc.ca/fn-an/alt_formats/pdf/label-etiquet/claims-reclam/assess-evalu/flaxseed-graines-de-lin-eng.pdf
67. Arjmandi BH, Khan DA, Juma S, Drum ML, Venkatesh S, Sohn E, Wei L, Derman R (1998) Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. Nutr Res 18:1203–1214. doi:10.1016/S0271-5317(98)00100-6
68. Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, Stoecker BJ, Arjmandi BH (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87:1527–1532. doi:10.1210/jcem.87.4.8374
69. Barre DE, Griscti O, Mizier-Barre KA, Hafez K (2005) Flaxseed oil and lipoprotein (a) significantly increase bleeding time in type 2 diabetes patients in Cape Breton, Nova Scotia, Canada. J Oleo Sci 54:347–354
70. United States Department of Agriculture (USDA) Agricultural Research Service (2007) National nutrient database for standard reference, Release 27 [cited 2015 February 17]. http://ndb.nal.usda.gov/ndb/foods/show/3745?fg=&man=&lfacet=&format=&count=&max=25&offset=&sort=&qlookup=flaxseed